Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04151966 · ClinicalTrials.gov registry record
Myocardial Injury Following Elective Direct Current Cardioversion for Atrial Arrhythmias
A clinical trial of Cardioversion, sponsored by Mayo Clinic.
- Completed
- Registry status
- 104
- Enrollment target
- 1
- Study location
NCT04151966: Completed study of Cardioversion, sponsored by Mayo Clinic.
NCT04151966 is a study of Cardioversion that has completed, run by Mayo Clinic. The registered enrollment target is 104 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04151966, a study of Cardioversion, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to determine if heart injury occurs in subjects who undergo direct current cardioversion.
Primary Outcome
Changes in high sensitivity cardiac troponin T (hs-cTnT) or troponin I (hs-cTnI) assay
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood sample collection
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2019-07-22 |
| Est. Completion | 2021-12-01 |
What the finished NCT04151966 record still lists
NCT04151966 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Cardioversion appearing as the primary indexed condition, and to 1 intervention - of which Blood sample collection is the first listed.
NCT04151966 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04151966 about?
NCT04151966 is a clinical study titled "Myocardial Injury Following Elective Direct Current Cardioversion for Atrial Arrhythmias". Researchers are trying to determine if heart injury occurs in subjects who undergo direct current cardioversion.
What is the current status of trial NCT04151966?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2019-07-22. Estimated completion is 2021-12-01.
What conditions does trial NCT04151966 study?
This clinical trial studies the following conditions: Cardioversion.
What interventions are being tested in trial NCT04151966?
The interventions under investigation include: Blood sample collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04151966?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04151966 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI